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Snap25
S187A/S187A mouse is a knock-in mouse with a single amino acid substitution at a protein kinase C-dependent phosphorylation site of the synaptosomal-associated protein of 25 kDa (SNAP-25), which is a target-soluble NSF attachment protein receptor (t-SNARE) protein essential for neurotransmitter release. Snap25 S187A/S187A mice exhibit several distinct phenotypes, including reductions in dopamine and serotonin release in the brain, anxiety-like behavior, and cognitive dysfunctions. Homozygous mice show spontaneous epileptic convulsions, and about 15% of the mice die around three weeks after birth. The remaining mice survive for almost two years and exhibit spontaneous recurrent seizures throughout their lifetime. Here, we conducted long-term continuous video electroencephalogram recording of the mice and analyzed the process of epileptogenesis and epileptic maturation in detail. Spikes and slowwave discharges (SWDs) were observed in the cerebral cortex and thalamus before epileptic convulsions began. SWDs showed several properties similar to those observed in absence seizures including (1) lack of in the hippocampus, (2) movement arrest during SWDs, and (3) inhibition by ethosuximide. Multiple generalized seizures occurred in all homozygous mice around three weeks after birth. However, seizure generation stopped within several days, and a seizure-free latent period began. Following a spike-free quiet period, the number of spikes increased gradually, and epileptic seizures reappeared. Subsequently, spontaneous seizures occurred cyclically throughout the life of the mice, and several progressive changes in seizure frequency, seizure duration, seizure cycle interval, seizure waveform, and the number and waveform of epileptic discharges during slow-wave sleep occurred with different time courses over 10 weeks. Anxiety-related behaviors appeared suddenly within three days after epileptic seizures began and were delayed markedly by oral administration of valproic acid. These results showed that Snap25 Introduction Epilepsy, a chronic neurological disorder that is characterized by recurrent spontaneous seizures due to neuronal hyperactivity in the brain, is the most common serious neurological condition, affecting more than 50 million people world-wide. Between 70% and 80% of people with epilepsy go into remission, and the remaining patients will continue to have seizures and will be resistant to antiepileptic drugs (AEDs). Thus, development of new AEDs and new method of treatment are urgently required. Much evidence exists to support the view that development of epilepsy is a process that should be treated as early and effectively as possible to try to prevent the development of chronic, intractable epilepsy (Reynolds, 1995) . Administration of proper doses of proper medications at a proper time is required for effective treatment, and thus, understanding the molecular and neuronal basis of epilepsy is important. Acquisition of epilepsy is thought to arise from a brain insult such as traumatic brain injury, stroke, status epilepticus, or infection/inflammation, and spontaneous recurrent seizures are thought to occur after a latent period. Acquired epilepsy is also often considered to be progressive, with seizures that occur more frequently and that increase in severity over time. These two distinct processes are designated "epileptogenesis" and "epileptic maturation", respectively (Pitkänen and Sutula, 2002; Dudek and Staley, 2011a, b) . To study the processes of epileptogenesis and epileptic maturation, continuous electroencephalogram (EEG) recording is inevitably necessary. However, obtaining continuous EEG records of human patients from the time of brain insult to the onset of clinical seizures is difficult because seizures are often initiated over a long period, ranging from several months to many years. Furthermore, many human patients receive AEDs to suppress the symptomatic or "early" seizures that are directly associated with the brain injury, and most patients are treated with AEDs after one or a few "late" (i.e., "epileptic") clinical seizures. Therefore, quantitative analysis of the temporal features of acquired epileptogenesis in humans independent of the effects of AEDs is nearly impossible. Thus, adequate animal models of epilepsy are necessary to understand the neuronal basis of epileptogenesis and epileptic maturation.
To date, many mutant mice with spontaneous epileptic seizures have been established using either gene engineering techniques or by isolating spontaneous mutants (Steinlein and Noebels, 2000; Meisler et al., 2001; Crunelli and Leresche, 2002; Upton and Stratton, 2003; Baraban, 2007; Zhu et al., 2008) . Animal models of acquired epilepsy have also been developed based on status epilepticus that is induced with administration of a chemo-convulsant drug (Coulter et al., 2002; Morimoto et al., 2004; Curia et al., 2008; Scorza et al., 2009) , electrical stimulation (Kalynchuk, 2000; Löscher, 2002; Morimoto et al., 2004; Sloviter and Bumanglag, 2013) , or hypoxic-ischemic brain injury (Williams et al., 2009; Kadam et al., 2010) . However, all models have some shortcomings. For example, some mice have a high mortality rate; epileptic animals are time consuming and labor intensive to establish; animals represent only the restrictive phenotype of epilepsy, etc. Because epilepsy is a heterogeneous disorder with multiple origins and many different mechanisms of pathogenesis among patients, multiple animal models with different origins and phenotypes are necessary to understand epileptogenesis and epileptic maturation.
The synaptosomal-associated protein of 25 kDa (SNAP-25) is a target-soluble NSF attachment protein receptor (t-SNARE) protein expressed in neurons and some secretory cells (Jahn and Fasshauer, 2012; Südhof, 2013) . SNAP-25 plays essential roles in neurotransmitter release and incorporation of ion channels and receptors into the plasma membrane by exocytosis (Jarvis and Zamponi, 2007; Pozzi et al., 2008; Selak et al., 2009; Lau et al., 2010) . SNAP-25 is phosphorylated by protein kinase C (PKC) at Ser 187 (Shimazaki et al., 1996) , and mutant mice with the single amino acid substitution S187A show very strong anxiety-like behaviors and cognitive dysfunctions (Kataoka et al., 2011 , Ohira et al., 2013 . Interestingly, all mutant mice have recurrent spontaneous epileptic seizures around three weeks after birth (Kataoka et al., 2011) . Despite repetitive epileptic seizures that occur throughout the lifespan of the mutant mice, the mice survive nearly 2 years, and thus, following the processes of epileptogenesis and epileptic maturation throughout life is possible. Here, we conducted continuous long-term video-EEG recording of Snap25 S187A/S187A mice. We also examined the effect of epileptic seizures on anxiety-like behaviors.
Materials and methods

Animals
All procedures involving animals complied with the guidelines of the National Institutes of Health and were approved by the Animal Experimentation and Ethics Committees of the Kitasato University School of Medicine. All efforts were made to minimize animal suffering and reduce the number of animals used. Snap25 S187A/S187A mice were generated as described previously (Kataoka et al., 2011) . Mice heterozygous at the Snap25 S187A locus were bred with C57BL/6 N mice (CLEA, Japan) and maintained using standard husbandry procedures. After back-crossing the mutant mice onto the C57BL/6 N genetic background 13 times, homozygous mice were routinely obtained with in vitro fertilization using ICR mice as foster mothers. They were maintained in a 14:10-h light-dark cycle with lights on beginning at 6:00 a.m. under constant temperature (23 ± 1 • C) in a room with a clean air conditioning system. One week before the first behavior experiment, they were handled once daily for three days.
Surgery
Under sevoflurane inhalation anesthesia (3-4% sevoflurane/oxygen flow 0.5 L/min) and subcutaneous injection of xylocaine, the mice were implanted with EEG and electromyogram electrodes. Bipolar electrodes (two stainless steel wires, 0.2 mm in diameter, tip separation 0.5 mm) were implanted in either the left dorsal hippocampus at posterior (P): 2.0 mm (from bregma), lateral (L): 1.4 mm (from the midline), and dorsal (D): −2.1 mm (from the dura) or the ventral posteromedial thalamic nucleus of the left thalamus at P: 2.2 mm (from bregma), L: 1.4 mm (from the midline), and D: −4.0 mm (from the dura). Three stainless steel miniature screws ( 1.0 mm), which served as epidural EEG electrodes, were placed over the left frontal cortex [anterior (A): 1.2, L: 1.0], right anterior region for the reference electrode (A: 2.5, L: 0.6), and right occipital region for the ground electrode (P: 2.5, L: 2.0). In addition, two Teflon ® insulated stainless steel micro-wires were inserted bilaterally and subcutaneously into the dorsal neck to record electromyograms. Dental cement was used to fasten the micro-connection socket to the surface of the skull. EEG recording was started on the day of surgery.
Electroencephalographic recordings
The hippocampal and thalamic EEGs were recorded between the long and short bipolar electrodes, and the cortical EEG was recorded between the anterior and frontal cortical screw electrodes. The signal from the recording electrodes was amplified and filtered (Time Constant: 0.01 s, high cut: 30 Hz). In addition, a 50-Hz notch filter was applied. The amplified signal was digitized at 500 Hz with a data translation A/D board and was recorded directly onto a PC hard drive using Multi Scope 2100 (Medical Try System). Simultaneously with the EEG recording, all mice were continuously video-monitored using two CCD cameras set in the diagonal direction during the experimental periods. Cameras were capable of infrared recording during the dark phase. Mice were housed with free access to food and water in clear plastic cages (one per cage) to allow optimal video observation in a sound-attenuating box. They were maintained in a 12:12-h light-dark cycle with lights on beginning at 8:00 a.m. The EEG recording was interrupted from 09:00-10:00 for cage cleaning and feeding.
Analysis of EEG data
All EEG data were analyzed with Multi Scope 2100 software. Because the absolute value of the EEG data varied among different mice and different experimental days, possibly due to different electrode conditions, a standard value for normalization was determined for each mouse on each experimental day. Averaged EEG values over 5 min were measured at five different time points in the aroused state each day, and the mean of these values was used as the standard value of the mouse on that day. For spike counting, the number of spikes in which the amplitude was 10 times larger than the standard value was counted. Seizures were identified with EEG and video monitoring.
Drug administration
Ethosuximide (ESM) was dissolved in saline and given to the mouse by i.p. injection (200 mg/kg). For continuous injection, an end of Teflon tube ( 1.0 mm) fixed onto the socket for the EEG electrode on the skull was inserted into the peritoneal cavity through the subcutaneous space, and another end was connected with a syringe pump (KDS-220, KD Scientific Inc.). The mouse was given ESM (1000-2000 mg/kg/day) continuously.
For other experiments, after weaning at 16 days old, Snap25 S187A/S187A mice and their wild-type littermate controls were fed powdered mouse chow with or without valproic acid (VPA) (10 g/kg chow before five weeks old and 20 g/kg chow after).
Antibodies
We used rabbit anti-glial fibrillary acidic protein (GFAP; Sigma), rabbit anti-neuropeptide Y (NPY; Peninsula Laboratories), HRPgoat anti-rabbit IgG and HRP-conjugated goat anti-mouse IgG + IgM antibodies (Jackson ImmunoResearch). A mouse monoclonal antibrain-derived neurotrophic factor (BDNF) antibody, which was generated against a synthetic peptide TMDSKKRIGWRFIR (residues 221-234 of rat proBDNF), was a kind gift from Dr. Makoto Itakura of Kitasato University School of Medicine.
Immunohistochemistry
Mice of various ages were deeply anesthetized with isoflurane and transcardially perfused with phosphate-buffered 4% paraformaldehyde. Brains were then removed from the calvaria, post-fixed overnight at 4 • C in 4% paraformaldehyde, processed for paraffin embedding, and cut at a thickness of 3 m. For immunohistochemical detection of GFAP and NPY, sections were first treated with 5 g/ml proteinase K (Dako) for 3 min at room temperature. Endogenous peroxidase activity was then inhibited by incubating the sections in 3% hydrogen peroxide/calcium-and magnesiumfree phosphate-buffered saline for 5 min. After treatment with blocking buffer (0.5% casein, 0.3 M NaCl, 0.1 M Tris-HCl, pH 7.5), the sections were incubated overnight at 4 • C with anti-GFAP or anti-NPY antibodies (1:3000), and the immune complexes were detected using a peroxidase-conjugated Fab' fragment of antirabbit antibody (Nichirei Bioscience), followed by staining with diaminobenzidine tetrahydrochloride substrate (Dako). In some experiments, we counterstained the sections with hematoxylin (Vector Lab) after immunostaining.
Western blotting
For western blotting, the hippocampus was removed and homogenized in 5 ml SDS sample buffer [70 mM SDS, 3.3% (w/v) glycerol, 0.03 mM bromophenol blue, 125 mM Tris-HCl, pH 6.8] in the presence of 20 mM DTT with an ultrasonicator. The samples were boiled, and the protein concentrations were determined using the BCA protein assay kit (Pierce). SDS-PAGE was performed on 12.5% or linear 10-20% (w/v) acrylamide gradient gels. Immunoblotting was performed with enhanced chemiluminescence (Amersham) as described previously (Iwasaki et al., 2000) . Anti-GFAP (1:1000), anti-BDNF (10 mg/L), HRP-conjugated goat anti-rabbit IgG (1:3000), and HRP-conjugated goat anti-mouse IgG + IgM (1:3000) were used.
Behavior experiments
General activity was measured in an open-field box placed in a sound-attenuated room. Mice were placed in the center of a brightly lit (650-700 lx) chamber of the apparatus (50 × 50 × 40 cm 3 ). Movements of the animals were tracked with the automatic monitoring system Lime Light (Actimetrics Inc.) for 30 min. Horizontal motor activity (distance traveled) and central activity (distance traveled in the central area/total distance traveled) were evaluated. The field was divided into 9 × 9 subareas, and the center area was defined as the inner 8 × 8 subareas. Central activity was calculated from the number of crossings in the central area divided by the number of total crossings.
The apparatus for the light and dark preference test consisted of two compartments of gray vinylchloride plates and was placed in a darkened, sound-attenuated room. One compartment was a bright (250 lx) chamber (25 × 50 × 40 cm 3 ) illuminated with a fluorescent lamp, and the other was a dark (0.5 lx) chamber (25 × 50 × 40 cm 3 ). The two compartments were separated by a wall with a small opening (8 × 16 cm 2 ). Two pairs of 24 × 24-array infrared photosensors were attached to the outer wall, equally spaced in rows 2.5 cm and 6.5 cm from the floor. The lower row of photocells was used to detect the location of the mouse, and the upper row was used to detect rearing behavior. The sensor state was sampled every 0.1 s. A mouse was placed in the center of the light chamber facing the opening, and its behavior was recorded by the computer for 30 min. The mouse was considered to have entered a new area when the center of the body was in this area. The apparatus was cleaned with 70% ethanol after each trial.
Statistics
Data are shown as the mean ± standard deviation (SD). Two groups were compared using the two-tailed, unpaired Student's t-test. Groups of three or more were analyzed with one-way or two-way ANOVA tests followed by Tukey-Kramer's honestly significant difference post-hoc test. A p value <0.05 was considered statistically significant.
Results
Epileptogenesis in Snap25 S187A/S187A homozygous mice Although individual differences were found among Snap25 S187A mice that were back-crossed 13 times onto the C57BL/6 N background, all Snap25 S187A/S187A mice showed essentially the same sequential process of epileptogenesis. We designated successive periods in the process as the pre-generalized seizure (GS) period, first GS period, latent period, and second GS period.
The youngest mouse from which we obtained continuous video-EEG recording was postnatal day 19 (P19) because the skull of younger mice was not fully hardened, and attaching chronic electrodes onto the head was difficult. No abnormal discharges in the EEG of the hippocampus were observed at P19, but we observed frequent spontaneous bursts of bilateral spikes and slow-wave discharges (SWD) in the cerebral cortex and thalamus in all Snap25 S187A/S187A mice ( Figure 1A and B). The waveform frequency of SWDs was 6.92 ± 0.71 Hz (range 6.3-8.2, median 6.6, n = 7 mice), which was very similar to those observed in other mutant mice exhibiting SWDs (Crunelli and Leresche, 2002) . SWDs were observed both in the light and dark periods, but SWDs often appeared in the aroused state or at the onset of slow-wave sleep (data not shown). The mean duration of the SWDs was 1.73 ± 0.39 s (range 1.31-2.33, median 1.65, n = 6 mice). SWDs observed in Snap25 S187A/S187A mice resembled those in absence seizures because (1) synchronized discharges were observed in the cortex and thalamus but not the hippocampus ( Figure 1A and B), (2) SWDs Figure 1 . SWDs found in the cerebral cortex and thalamus of Snap25 S187A/S187A mice before the onset of the first GS period. A. Simultaneous EEG recordings from two brain regions per mouse were performed with unanesthetized, free-moving Snap25 S187A/S187A mice at the age of 23 days [A-1; cerebral cortex (C, red) and hippocampus (H, blue)] and 25 days [A-2; cerebral cortex (C, red) and thalamus (T, green)]. Expanded EEGs during the periods indicated by the blue and green lines are shown on the bottom. Synchronous firing of SWDs appeared in the cerebral cortex and thalamus, but not the hippocampus. The animal displayed brief behavior arrest during SWDs. Vertical red, blue, and green lines are the voltage scale of cerebral cortical, hippocampal and thalamic EEGs, respectively. B. The mean power spectrums of EEGs during SWDs obtained from a pair of recordings from the cerebral cortex (C, red) and hippocampus (H, blue) (left), and from the cerebral cortex (C, red) and thalamus (T, green) (right). High, sharp peaks appeared at 6.92 ± 0.71 Hz and at multiple Hz in the cerebral cortex and thalamus, but not in the hippocampus. The mean values of five SWDs are shown. C. Suppression of SWDs by ESM. The number of spikes per minute was counted, and the average value in every 15 min + SEM is shown. Top, ESM (200 mg/kg) was given by a single i.p. injection at the time indicated by the green arrow. Bottom, ESM (1000 mg/kg/day) was given continuously during the period indicated by the green underline. ESM reversibly suppressed SWD. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Figure 2. Typical process of epileptogenesis in Snap25
S187A/S187A mice. A. Continuous video-EEG recording was conducted from P21 to P33, and the numbers of spikes in the cerebral cortex (red circles) and hippocampus (blue circles) per hour were plotted against time from P21 to P27. Yellow and blue lines below the horizontal axis indicated the light (08:00-20:00) and dark periods (20:00-08:00) of each day. This is a typical example selected from recordings of nine mice. Despite individual differences in the length of each period, all mice showed essentially the same process as shown in this figure. The process can be divided into several characteristic periods. Characteristic features of each period and abbreviations used in this figure are as follows: Pre-GS period (Pre-GS), SWDs appeared but GSs had not yet appeared; First GS period (1st GS), suddenly began at 23.1 ± 3.6 postnatal days after the first spontaneous GS and automatically stopped within 41.3 ± 14.8 h. The times of GS firing are indicated by arrows: Latent period, a period with no GSs. The latent period was divided into three periods: Post-GS hyper-activated period (HA), monophasic and biphasic spikes and spike clusters were observed in both the cerebral cortex and hippocampus after the first GS period. However, the number of spikes decreased gradually; Quiet period (Q), a period with few spikes (fewer than one per min) in the cortex and hippocampus. Suppression seizure, in which a sudden decrease in the amplitude of hippocampal EEG was observed in seven out of 10 mice (Purple arrow in Figure 2B , also see Figure 3A) ; Reactivated period (R1-R4), a period with monophasic and biphasic spikes of large amplitude and spike bursts mainly in the cerebral cortex; Second GS period (2nd GS), a period with spontaneous recurrent GSs that continued throughout life. B. A typical example of cortical (C, red) and hippocampal (H, blue) EEGs of GSs during the first GS period. C. Typical examples of cortical (C, red) and hippocampal (H, blue) EEG waveforms that appeared during each period as shown in A. Time expansion of ictal spikes marked with green triangles is shown on the right. Vertical red and blue lines on the right of EEG records are the voltage scale of cerebral cortical (200 V) and hippocampal EEGs (300 V), respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) disappeared following injection of ESM ( Figure 1C ), and (3) SWDs were accompanied by behavioral arrest. SWDs disappeared with the onset of GSs during the first GS period (data not shown).
All Snap25 S187A/S187A homozygous mice suddenly exhibited convulsive seizures around three weeks after birth (23.1 ± 3.6 days, range 19-30, median 23, n = 17 mice) without any auras (Figure 2A and B). The first seizure seemed to be generalized because synchronized seizures were observed in multiple sites in the brain including the cerebral cortex, hippocampus, and thalamus ( Figure   S1 ) and were always accompanied by convulsions. The severity of the convulsions varied among the ensuing seizures, and some seizures were not accompanied by convulsions. GSs often appeared in the beginning of slow-wave sleep (data not shown). This first period of GS generation was relatively short, lasting on average 41.3 ± 14.8 h (range 17-59, median 43, n = 8 mice). The total number of GSs during this first GS period varied with an average of 45.6 ± 19.1 times/first GS period (range 21-81, median 46.5, n = 8 mice). A-1, EEG waveform of the cerebral cortex (C, red) and hippocampus (H, blue) during a suppression seizure. A-2, averaged value of EEG amplitude during the period indicated with the purple line in A-1 was calculated every 2 min for the cerebral cortex (red) and hippocampus (blue) and was plotted against time as the relative value to the initial value. The amplitudes of cortical EEGs remained constant, whereas that of hippocampal EEGs decreased with a half-life of 8.9 s. The suppression seizure appeared only during the latent period and was observed in seven out of 10 mice tested. B. High-frequency hippocampal discharge. Expanded EEGs during the period indicated with the green lines (a and b) are shown on the bottom. The seizure was composed of periodic discharge of spike complex and appeared only in the hippocampus and not in the cerebral cortex. The high-frequency hippocampal discharge appeared only during the latent period and was observed in four out of 10 mice tested. Vertical red and blue lines are the voltage scale of cerebral cortical and hippocampal EEGs, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Following the first GS period, a GS-free latent period appeared ( Figure 2A ). Although individual variations were present in the duration of the latent period (105.4 ± 29.6 h, range 63-147, median 102, n = 7 mice) and in the appearance of spike discharges, all mice showed essentially the same latent period. Even after ceasing GSs, spike discharges continued for a while (57.3 ± 35.6 h, range 14-118, median 62, n = 7 mice) in both the cerebral cortex and hippocampus with a gradual decline in frequency (Figure 2A , post-GS hyperactivated period, HA). Following HA, a quiet period (Q) appeared in all Snap25 S187A/S187A mice (Figure 2A and C) during which no spike discharges were observed in the cerebral cortex or hippocampus. A large variation in duration of the quiet period was also observed (25.7 ± 12.8 h, range 7-44, median 26, n = 7 mice). Spike discharges reappeared prior to regeneration of GSs at the onset of the second GS period (Figure 2A , reactivated period, R1-4) with a duration of 22.4 ± 19.2 h (range 2-47, median 13, n = 7 mice). Both unipolar and bipolar spikes with large amplitudes were observed during the latent period except for the quiet period ( Figure 2C ). Two types of hippocampal seizures sometimes appeared during the latent period, including suppression seizures (purple arrow in Figure 2C and Figure 3A ) and high-frequency hippocampal discharges ( Figure 3B ), which were observed in 7/10 and 4/10 mice, respectively. S187A/S187A mouse from P22 to P85, and the GS number per day was plotted against postnatal day. Right, the peak interval of GS (average ± SD) in different ages of mice. <11 weeks, 5-11 weeks old, n = 9 in 2 mice; <43 weeks, 30-43 weeks old, n = 4 in 6 mice; <73 weeks, 70-73 weeks old, n = 4 in 2 mice. Statistical analysis was performed with one-way ANOVA followed by TukeyKramer's honestly significant difference post-hoc test. B. Number of GSs per day at different postnatal ages. Left, average number of GSs per day (n = 4-17/mouse) was calculated at various postnatal days in 19 mice and was plotted against postnatal days. Right, average number of GSs per day at different ages. <4 weeks, 5.6 ± 1.8 (average ± SD, n = 6 mice); >10 weeks, 14.7 ± 3.0 (average ± SD, n = 15 mice). Statistical analysis was performed with the Student's t-test. C. Duration of GSs. Left, GS duration was measured (n = 12-69 GS/mouse) in 19 mice, and the means were plotted against postnatal days. Right, average value of GS duration at different ages. <11 weeks, 19.6 ± 1.6 (average ± SD, n = 6 in 5 mice); <43 weeks, 26.8 ± 6.4 (average ± SD, n = 12 in 10 mice). p = 0.0162 (Student's t-test).
After the latent period, GSs again appeared frequently, and the brain appeared to be fully epileptic (second GS period, Figure 2A , second GS). The average age of onset of the second GS period was P30.2 ± 2.9 (range 26-36, median 29.5, n = 14 mice). In striking contrast to the first GS period, appearance of GSs during the second GS period did not stop automatically and continued throughout the mouse's life. The number of spontaneous GSs every day changed cyclically (Figure 4A , left) as reported in a pilocarpine model (Goffin et al., 2007; Mazzuferi et al., 2012) . GSs appeared Figure 4A . Postnatal day is shown on the left. Yellow and blue bars on the bottom indicate the light period (from 08:00 to 20:00) and dark period (from 20:00 to 08:00), respectively. GSs appeared both during the light period and dark period, but they tended to appear in clusters on the day of the peak in GS number (P29, P38, P50, P63, and P79). GSs were less frequent on the next day. B. EEG profiles of the cerebral cortex (C, red) and hippocampus (H, blue) during the periods indicated with the two blue lines (a and b) in Figure 5A at P58. No cortical spikes were observed, even 3 h after a cluster of GSs. Arrows at P80 indicate the times of EEG recordings shown in Figure 7A . Vertical red and blue lines are the voltage scale of cerebral cortical and hippocampal EEGs, respectively. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) in both the light and dark periods, but sometimes GSs appeared in a cluster, especially on the peak day of GS generation in the cycle ( Figure 5A ; P29, P50, P58, P63, and P79). We observed 18 GSs at the most in 10 min. Interestingly, a quiet period with no seizures and no spikes appeared several hours after the GS cluster ( Figure 5B ). GS generation tended to be spread out over most of the day on the next day of GS clusters ( Figure 5A ; P51, P59, P64, and P80). . Progressive changes in GS waveforms. GSs were composed of two phases, an early phase and a later phase. A remarkable change in the waveform compared to the preceding phase was seen. A. Top, typical waveform of EEG that was dominant in young mice. C, cerebral cortex (red); H, hippocampus (blue). The region marked with the green line is expanded on the bottom left. The early phase of this type was composed of continuous irregular spikes. Bottom right, power spectrum of cortical (red) and hippocampal EEG (blue) in the region marked with the green line in the top chart. No sharp peak was observed. Vertical red and blue lines are the voltage scale of cerebral cortical and hippocampal EEGs, respectively. B. Top, typical waveform of EEG that was dominant in older mice. C, cerebral cortex (red); H, hippocampus (blue). The region marked with the green line is expanded on the bottom left. Bottom right, power spectrum of cortical (red) and hippocampal EEG (blue) in the region marked with the green line in the top chart. The early phase of this type of GS was composed of continuous monotonic spikes. A very sharp peak appeared at 16 and 33 Hz in the power spectrum. Vertical red and blue lines are the voltage scale of cerebral cortical and hippocampal EEGs, respectively. C. Power spectrums of the selected period (2 s) in the early phase of the EEG were obtained from 10 mice of various ages. Fourteen to 44 power spectrums were obtained per mouse. GSs were classified into three groups, and their ratio was represented as the percentage of total GSs in each mouse. The ratio was at two different ages in two mice. GS was judged to have synchronized in the early phase if the peak value of the power spectrum was more than 5%. White box, GS with no synchronization in the early phase; gray box, GS with a synchronized early phase in either the cortex or hippocampus; black box, GS with synchronization in the early phase in both the cortex and hippocampus. The ratio of GSs with a synchronized early phase increased remarkably between 3 and 10 weeks after birth. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Progress in epileptic maturation
Snap25 S187A/S187A mice continued to exhibit epileptic spikes and GSs over their entire lifespan. However, several distinct progressive changes in the EEG profile were observed. The peak interval of the GS cycle was 8.2 ± 1.8 days (range 5-11, n = 9 in 2 mice) for mice younger than 11 weeks old, but it decreased with age and was 4.4 ± 1.7 days (range 2-7, n = 9 in 6 mice, p = 0.0003) and 2.8 ± 1.0 days (range 2-4, n = 4 in 2 mice, p = 0.0001) for mice at 30-43 and 70-73 weeks old, respectively ( Figure 4A, right) . On the other hand, the number of GSs per day increased significantly (p < 0.00001) between 5 and 10 weeks after birth [5.6 ± 1.8 times/day (n = 6 mice) and 14.7 ± 3.0 times/day (n = 15 mice) for mice less than 5 weeks old and older than 10 weeks old, respectively] ( Figure 4B ). Age-dependent dramatic changes were also seen in the waveform of GSs. Seizures with longer durations appeared in mice older than 10 weeks ( Figure S2 ), and the average seizure duration increased significantly (p = 0.0162) from 19.6 ± 1.6 s (n = 6 in 5 mice) to 26.8 ± 6.4 s (n = 12 in 10 mice) between 10 and 20 weeks of age ( Figure 4C ). Furthermore, a striking change in the shape of GS discharges occurred between 3 and 10 weeks after birth. A typical waveform of GS was composed of two phases, an early phase that was composed of continuous spike-wave discharges with variable amplitudes, and a later phase that was composed of spike clusters separated by suppressed periods (Figure 6A, upper) . In mice younger than four weeks, the early phase of a large population of epileptic seizures was composed of continuous spike-wave discharges with variable amplitudes ( Figure 6A , bottom left), and no prominent peak was observed in the power spectrum of the preceding phase ( Figure 6A , bottom right). In contrast, GSs of the mice older than four weeks often showed an early phase composed of very regular monotonic waves ( Figure 6B , upper) and prominent peaks that appeared in the power spectrum ( Figure 6B , bottom right). The percentage of seizures with a monotonic phase increased remarkably between 3 and 10 weeks after birth ( Figure 6C) .
A striking progressive change in spikes during slow-wave sleep occurred in the cerebral cortex and hippocampus over time. Spikes with large amplitudes often appeared in the hippocampal EEG Figure 4A (left) and Figure 5 at various postnatal days. Expanded EEGs during the period indicated with the purple line are shown on the right. GS did not occur on P23, P47, or P84, but occurred on P80. EEG records labeled "a" and "b" in P80 were obtained during an intra-GS cluster period and 4.5 h after cessation of the GC cluster, respectively, as indicated by the arrows in Figure 5A at P80. In the hippocampus, the number of sharp spikes with high amplitudes increased with age. However, large-amplitude spikes were rarely observed in the cerebral cortex on days with no GSs. In contrast, hippocampal spikes were observed in clusters separated by a refractory period, and synchronized firing of cortical spikes appeared on days with GSs [P80 (a)]. After cessation of the GS cluster, the number of cortical spikes decreased gradually, and coupling with the hippocampus became less obvious [P83 (b)]. Vertical red and blue lines on the right of EEG records are the voltage scale of cerebral cortical (100 V) and hippocampal EEGs (500 V), respectively. B. Total number of spikes per day in the cerebral cortex (red circles) and hippocampus (blue circles) in days with no GS. Despite the number of hippocampal spikes that increased markedly up to 12 weeks after birth, the number of cortical spikes rarely increased during this period. C. The total number of spikes per day in the cerebral cortex (red bars) and hippocampus (blue bars) in days with no GSs at different ages. 3-5 weeks, n = 22 in 7 mice; 6-12 weeks, n = 24 in 2 mice; 21-26 weeks, n = 7 in 3 mice; 33-44 weeks, n = 12 in 3 mice; >70 weeks, n = 5 in 2 mice. Statistical analysis was performed using one-way ANOVA followed by Tukey-Kramer's honestly significant difference post-hoc test. Spike number in the hippocampus increased significantly (p = 0.0002) between 3-5 weeks and 6-12 weeks, whereas that of the cerebral cortex increased between 21-26 weeks and 33-44 weeks (p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) during the interictal period ( Figure 7A ; P47); these were not found during the latent period ( Figure 7A; P23) . Most of these spikes were biphasic, although monophasic spikes were also observed. The number of hippocampal spikes in a GS-free day increased remarkably from 3 weeks of age and attained a plateau around 12 weeks of age (Figure 7A and B; P84Figure). In contrast, the number of cortical spikes did not significantly increase during the same period (Figure 7A and B; P47 and P84Figure).
The pattern of spike generation was strongly affected by GSs. The waveform of hippocampal spikes during slow-wave sleep was Figure 8 . Effect of ESM on the onset of the first GS period. A. Free-moving mice with no GSs were continuously given ESM (1000-2000 mg/kg/day) from P20 by i.p. administration through a Teflon tube connected to a syringe pump, and the average day of the first GS was compared with mice not given ESM. Because some control mice had already experienced a GS on the first day of measurement, the initial day of recording was regarded as the onset of GS. A. Average ± SD for ESM-treated (ESM, green bar, n = 8 mice) and untreated mice (Cont, brown bar, n = 17 mice). p = 0.00011 (Student's t-test) . B. total number of GSs during the first GS period was plotted against the day of the initial GS for ESM-treated (green triangles) and untreated mice (brown circles). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) quite different between days with ( Figure 7A , P80) and without GSs ( Figure 7A , P84) (see also Figure S3 ). In days with GSs, multiple spikes appeared in a cluster that was separated by refractory periods, and synchronized discharge of spike burst was observed in the cerebral cortex [ Figure 7A, P80 (a) ]. This characteristic pattern repeated at a frequency of about 0.5 Hz. However, the cyclic clustering of spikes became less obvious, and the number of cortical spikes decreased gradually after cessation of the GS cluster [ Figure 7A , P80 (b)]. In contrast, hippocampal spikes continued to appear throughout almost the entire day ( Figure S4A ). In 42-weekold mouse, cortical spikes were also found in the period with no GSs ( Figure S4B ). The number of cortical spikes increased remarkably around 30 weeks after birth, whereas no significant further increases in hippocampal spikes were observed during this period ( Figure 7C ). Interesting EEG waveforms look like premature form of GS often appeared in days with GSs, which suggested a possibility that prolongation of synchronized cortical and hippocampal spike discharges may develop into epileptic seizures ( Figure S5 ).
Effect of ESM on epileptogenesis
As described above, ESM effectively suppressed SWDs during the pre-GS period. Continuous administration of ESM also significantly delayed the appearance of initial GS discharges during the first GS period. The average day of initial GS appearance in control mice was 23.1 ± 3.6 days (range 19-30, median 23, n = 17 mice), whereas that in ESM-treated mice was 29.6 ± 2.4 days (range 27-34, median 29.5, n = 8 mice) ( Figure 8A , p = 0.00011). However, ESM did not inhibit GS generation, and the total number of GSs during the first GS period was significantly (p = 0. 0115) higher in ESM-treated mice (85.8 ± 34.1, range 41-131, median 86, n = 8 mice) than in control mice (45.6 ± 19.1, range 21-81, median 46.5, n = 8 mice). Because the number of GSs during the first GS period tended to increase with a delayed onset of initial GSs (Figure 8B ), the apparent increase in the GS number in ESM-treated mice might not a primary but a secondary effect of ESM, however, the additional studies will be required to clarify this problem.
Progressive changes in brain structure
Histochemical and biochemical analysis revealed that dramatic changes in brain structure began to occur around three weeks after birth in Snap25 S187A/S187A mice. NPY immunoreactivity dramatically increased in several brain regions, including the hippocampus ( Figure 9A ) and cerebral cortex (data not shown) of Snap25 S187A/S187A mice. NPY immunoreactivity in the inner molecular layer of the dentate gyrus was not detected at 10 weeks of age ( Figure 9A-2) but was detected at 18 weeks of age ( Figure 9A -3, triangles) in Snap25 S187A/S187A mice, indicating that a profound sprouting of mossy fibers occurs at 18 weeks of age but not at 10 weeks of age (see Scharfman et al., 2000; Borges et al., 2003) . GFAP immunohistochemistry revealed many reactive astrocytes in the hippocampus ( Figure 9B ) and the cerebral cortex (data not shown) in Snap25 S187A/S187A mice at both 10 ( Figure 9B -2) and 18 weeks of age ( Figure 9B-3) .
Quantitative immunoblotting revealed no significant difference in hippocampal GFAP expression between wild-type and Snap25 S187A/S187A mice at three weeks after birth; however, GFAP expression increased thereafter in Snap25 S187A/S187A mice and reached a maximum around 10 to 15 weeks after birth ( Figure 9C -1 and C-2). BDNF expression was also elevated in the hippocampus of Snap25 S187A/S187A mice, but was not significantly higher than in wild-type mice at postnatal day 23. Expression then increased markedly with development and attained a maximum around 10 weeks after birth ( Figure 9C -1 and C-3).
Rapid appearance of anxiety-like behaviors with GSs
Consistent with our previous study (Kataoka et al., 2011) , Snap25 S187A/S187A mice exhibited very strong anxiety-related behavior at five weeks of age including avoidance of the bright chamber in the light and dark preference test ( Figure S6A ) and thigmotaxis in the open-field test ( Figure S6B) . Surprisingly, Snap25 S187A/S187A mice behaved quite normally at three weeks of age (Figs. S6A and S6B) . To identify the critical period for the dramatic change in behavior, we conducted these behavior tests at various days after birth. In the light and dark preference test, the percentage of time wild-type mice remained in the light room was almost constant throughout the experimental period. On the other hand, Snap25 S187A/S187A mice did not show a strong preference three weeks after birth, and the value decreased rapidly thereafter (Figure S6A, bottom) . Anxiety-related behavior also appeared during the same period in the open-field test ( Figure S6B, bottom) .
Because many phenotypes of Snap25 S187A/S187A mice appeared from three weeks onward during the postnatal period, we analyzed the temporal correlation of epileptogenesis and the appearance of anxiety-related behavior in mice that did not show anxiety-related behavior at the beginning of EEG measurement. We defined the appearance of anxiety-related behavior as when the percentage of time at which a Snap25 S187A/S187A mouse stayed in the light room was less than the average value minus 2 SD of wild-type mice. Figure 10A shows a typical trace. No anxiety-related behavior was observed at postnatal day 24; however, the mouse had GSs 53 times between postnatal days 24 and 27. Quite interestingly, the behavior changed dramatically within only three days of when the repeated GSs began and showed very strong anxiety-related behavior at day 27 and after. As summarized in Figure 10B , all seven mice had multiple GSs within three days before demonstrating anxiety-related behavior. These results suggest that the anxiety-related behavior in Snap25 S187A/S187A mice was induced by multiple GSs.
To investigate the role of multiple epileptic seizures in the development of anxiety-related behavior, we administered VPA to wild-type and Snap25 S187A/S187A mice beginning at 16 days after birth. As shown in Figure 10C -1 and C-2, avoidance of the light Figure 9 . A and B. Expression of NPY (A) and GFAP (B) in the hippocampus of wild-type mice at 19 weeks of age (A-1 and B-1) and Snap25 S187A/S187A mice at 10 (A-2 and B-2) and 18 weeks of age (A-3 and B-3). Scale bar, 200 m. Sprouting of NPY-positive mossy fiber terminals (marked by triangles) appeared in 18-week-old mice (A-3) but not in 10-week-old Snap25 S187A/S187A mice (A-2). On the other hand, reactive astrocytosis was obvious at 10 weeks of age (B-2). C. Quantification of GFAP and BDNF expression in the hippocampus. (C-1) Immunoblot of hippocampal homogenates from wild-type mice (left two lanes) and Snap25 S187A/S187A mice (right two lanes) on postnatal day 23 (upper four lanes) and postnatal day 79 (lower four lanes) probed with either anti-GFAP or anti-BDNF antibody as indicated on the left. (C-2) Amount of GFAP in the hippocampus as determined with quantitation of the immunoblot of wild-type (red circles) and Snap25 S187A/S187A mice (blue circles) at various postnatal days. (C-3) Amount of BDNF in the hippocampus as determined with a quantitative immunoblot of wild-type (red circles) and Snap25 S187A/S187A mice (blue circles) at various postnatal days. Values represent the mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey-Kramer's honestly significant difference post-hoc test. *** p < 0.0001; ** p < 0.001 between wild-type and Snap25 S187A/S187A mice of the same age.
room was markedly suppressed in VPA-treated Snap25 S187A/S187A mice, and the percentage of photobeam crossings in the light room was comparable to that of wild-type mice at five weeks of age ( Figure 10C-2) . In the open field test, thigmotaxis was not apparent in VPA-treated Snap25 S187A/S187A mice ( Figure 10C -3 and C-4). The suppression was incomplete, and no significant difference was observed between eight-week-old mice with or without VPA administration.
Discussion
We conducted long-term continuous video-EEG recordings of Snap25 S187A/S187A mice and found that all mutant mice followed essentially the same process of epileptogenesis despite some individual differences. We also found that the mice demonstrated epileptic maturation, and several distinct progressive changes were identified in EEG over the 10 weeks after the onset of spontaneous GSs. The mutant mice also showed very strong anxiety-like behaviors after repeated GSs. However, the process proceeded much faster than epileptic maturation and occurred within a few days of the onset of GSs.
Three types of epileptic seizures found in Snap25 S187A/S187A mice Snap25 S187A/S187A mice showed at least three different types of epileptic seizures. The first type was SWDs, which were observed as early as 19 days after birth. SWDs showed typical characteristics of the absence seizures, including (1) a waveform and frequency of discharge, (2) movement arrest, (3) synchronized firing of the cortex and thalamus, and (4) sensitivity to ESM. Heterozygous Coloboma mutant mice with chromosomal deficiency in a region containing Snap25, in which expression of SNAP-25 is half of that in wild-type mice, exhibit SWDs beginning at 14-15 days after birth (Zhang et al., 2004) . Although the expression level of SNAP-25 in Snap25 S187A/S187A mice is also half that in wild-type mice (Kataoka et al., 2011) , heterozygous Snap25 knock-out mice do not show S187A/S187A mice. C-1, Typical traces of wild-type (Wt) and Snap25 S187A/S187A mice in the light-dark preference test with (+VPA) or without (−VPA) administration of VPA beginning 16 days after birth. C-2, Percentage of photobeam crossings in the light room in wild-type (Wt) and Snap25 S187A/S187A mice with or without VPA at the ages of 37 and 35 days, respectively. C-3, Typical traces of wild-type (Wt) and Snap25 S187A/S187A mice in the open-field test with (+VPA) or without (−VPA) administration. C-4, Percentage of distance traveled in the central area in wild-type (Wt) and Snap25 S187A/S187A mice with or without VPA at the ages of 35 and 37 days, respectively. ** p < 0.01 between with and without VPA, with two-way ANOVA with Tukey-Kramer's honestly significant difference post-hoc test. Number of mice are shown in parenthesis.
SWDs despite this reduced expression of SNAP-25 (Corradini et al., 2014) . These results suggest that a decline in SNAP-25 expression alone is not sufficient for the appearance of SWDs, and additional risk factors may be necessary. The PKC-dependent phosphorylation site is mutated in Snap25 S187A/S187A mice. Interestingly, the missing chromosomal region in Coloboma mice contains a gene encoding phospholipase C␤1, which generates diacylglycerol, a second messenger that activates PKC. Thus, concomitant reductions in SNAP-25 protein and PKC-dependent signaling activity are likely essential for the appearance of SWDs. T-type Ca channels play a critical role in the expression of SWDs. However, none of the mutant animals with SWDs has a mutation in the gene encoding the T-type Ca channel itself (Crunelli and Leresche, 2002; Chen et al., 2014) . Further studies are necessary to determine how various mutant proteins enhance T-type Ca channel activity in these mutant animals and Snap25 S187A/S187A mice.
The second and third types of seizures were GSs appeared in two distinct periods. The onset of the first period was 23.1 ± 3.6 days after birth and lasted for 41.3 ± 14.8 h. After a latent period, GSs reappeared during the second GS period. Unlike the first GS period, generation of GSs during the second GS period continued throughout the mouse's entire life with cyclical changes in the number of GSs. Two possibilities can be considered for the relationship between GSs in the first and second GS periods. First, some inhibitory mechanism may have converted the first GS period to the latent period, and this was terminated at the end of the latent period. Thus, GSs appeared again during the second GS period. Second, repeated GSs during the first GS period may have been an "initial precipitating injury" (Mathern et al., 2002) , similar to status epilepticus in the pilocarpine and kainic acid models, inducing spontaneous GSs during the second GS period. The second possibility appears more probable because the sequential process after the first GS period resembles that in the pilocarpine and kainic acid models (Curia et al., 2008) , although further studies are needed.
As described above, the expression level of SNAP-25 in Snap25 S187A/S187A mice is half that in wild-type mice. No GSs are observed in heterozygous Coloboma or Snap25 knock-out mice (Zhang et al., 2004; Corradini et al., 2014) , in which the expression level of SNAP-25 is also half that in wild-type mice. Thus, spontaneous GSs are not only due to a reduction in SNAP-25 protein. SNAP-25 has two splice variants, SNAP-25a and SNAP-25b. SNAP-25a is inferior to SNAP-25b for supporting synchronous neurotransmitter release (Sorensen et al., 2003; Delgado-Martinez et al., 2007) . Tkneo-containing SNAP-25b-deficient mice express only 80% of the normal SNAP-25 level and exhibit many epileptic seizures by two weeks after birth. However, removal of the selection gene Tkneo reduces the severity of the phenotype, and spontaneous seizures occur less frequently and not prior to young adulthood (Johansson et al., 2008) . Because PKC-dependent SNAP-25 phosphorylation is likely to involve enhanced exocytotic activity, reduced expression and activity of SNAP25 likely synergistically contributed to the expression of GSs. Recently, a human patient with severe generalized epilepsy was reported to have the genetic mutation V48F in SNAP-25 (Rohena et al., 2013) . Determining whether the mutation affects the expression level and/or function of SNAP-25 will be very interesting.
PKC-dependent SNAP-25 phosphorylation is involved in regulation of neurotransmitter release by exocytosis, and dopamine and serotonin release is markedly reduced in the amygdala of phosphorylation site-deficient Snap25 S187A/S187A mice (Kataoka et al., 2011) . Because ␥-aminobutyric acid and serotonin suppress epilepsy (Bagdy et al., 2007) , inadequate regulation of release of these neurotransmitters may cause epilepsy. On the other hand, SNAP-25 is also involved in incorporation of some ion channels and receptors into the plasma membrane by exocytosis (Jarvis and Zamponi, 2007; Pozzi et al., 2008; Selak et al., 2009; Lau et al., 2010) and regulation of ion channel function through direct binding (Jarvis and Zamponi, 2007) . SNAP-25 phosphorylation regulates the incorporation of Ca channels and glutamate receptors into the plasma membrane (Pozzi et al., 2008; Lau et al., 2010) , and thus, abnormal distribution of ion channels and/or receptors due to a mutant SNAP-25 phosphorylation site may cause epileptic discharges and seizures. Further studies are necessary to test these hypotheses.
Process of epileptogenesis
In the present study, we conducted continuous video-EEG recordings beginning in three-week-old mice and successfully recorded the process of epileptogenesis. Generation of GSs during the first GS period automatically stopped within 41.3 ± 14.8 h, suggesting that some suppressive mechanism initiated the shift to the subsequent latent period. Suppression seizures, which we observed in the hippocampus (see also Figure 3 ), may be a possible mechanism for the suppression. Determination of the mechanism and physiological significance of suppression seizures will be necessary in future studies.
In human patients, the interval between brain injury and the first spontaneous seizure can range from months to years (Annegers et al., 1998) . A seizure-free latent period following the "initial precipitating injury" has been reported in various animal models of acquired epilepsy (Dudek and Staley, 2011a, b) . In early studies with non-continuous video-EEG recording, the mean latency period was estimated between 10 and 18 days. However, recent studies using continuous video-EEG monitoring demonstrated that the first spontaneous seizure occurs within a few days after status epilepticus (Raol et al., 2006; Goffin et al., 2007; Bumanglag and Sloviter, 2008) . Using continuous video-EEG monitoring, we found a seizure-free latent period in all Snap25 S187A/S187A mice, despite individual differences in the duration. We also found that the latent period consisted of at least three different periods, the post-GS hyper-activated period, the quiet period, and the reactivated period. Two hypothesis have been suggested for the development of epilepsy, a step function and a continuous-function hypothesis (Williams et al., 2009; Dudek and Stanley, 2011a, b) . Our current study is more consistent with the latter possibility.
Epileptic maturation
Although discussion remains, many clinical observations have suggested that human temporal lobe epilepsy is often progressive (Pitkänen and Sutula, 2002; Blume, 2006) . In many animal models of epilepsy, the frequency of seizures increases over time Cornett, 1993, 1994; Hellier et al., 1998; Nissinen et al., 2000; Williams et al., 2004; Kadam and Dudek, 2007; Williams et al., 2009; Kadam et al., 2010) . However, several opposite reports have been published (Gorter et al., 2001; Bortel et al., 2010) , and a general consensus has not been obtained. Here we showed distinct progressive changes in the frequency, duration time, waveform of seizures, and epileptic spikes during slow-wave sleep, over 10 or more weeks after birth. Because these changes did not occur coincidentally, several different mechanisms seem to underlie these progressive changes.
In pilocarpine-and kainic acid-induced epileptic model mice, a profound sprouting of mossy fibers occurs, and NPY immunoreactivity appears in the inner molecular layer of the dentate gyrus of the hippocampus as early as 10 days after status epilepticus (Scharfman et al., 2000; Borges et al., 2003) . We observed various changes in brain structure, including mossy fiber sprouting, reactive astrocytosis, and upregulation of BDNF in Snap25 S187A/S187A mice, but further studies are needed to determine the molecular and cellular basis of progressive changes in epileptic maturation.
Appearance of anxiety-like behaviors
In human epileptic patients, anxiety and its related psychopathological conditions are widely observed (Kanner, 2004) . Anxiety-like behaviors and cognitive deficits appear in animal models of epilepsy induced by pilocarpine and kainic acid treatment. However, the process has not been studied precisely because these behavior tests were conducted several weeks or months after status epilepticus began (Gröticke et al., 2007; Müller et al., 2009 ). In the present study, we found that anxiety-like behavior appeared only a couple of days after repeated GSs began. Furthermore, we found that the appearance of the anxiety-like behavior was significantly delayed by administration of VPA. These results indicate that the appearance of anxiety-like behavior and the progression of epilepsy occurred through distinct changes in brain structure, the former was rapid changes induced by repeated GSs and the latter was slower changes followed by repeated GSs.
Utility of Snap25 S187A/S187A mice as an animal model of epilepsy Epilepsy is a heterogeneous disorder with multiple origins, and many mechanisms of pathogenesis exist among patients. Thus, multiple animal models with different origins and phenotypes are necessary for understanding epileptogenesis and epileptic maturation. Snap25 S187A/S187A mice have various advantages as an animal model of epilepsy. First, preparation of a large number of homozygous mice with in vitro fertilization is easy. Second, despite severe GSs throughout the entire lifespan of the mice, mortality is quite low, and most mice survive nearly 2 years (Kataoka et al., 2011) . Thus, Snap25 S187A/S187A mice will be useful for screening of AEDs, and observing the effects of various AEDs given at various times during epileptogenesis and epileptic maturation will be interesting.
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